Printer Friendly

Prior Authorization & Medication Quantity Limits

dotted line

Medicare

  • Using Medicare-defined rules and guidance, Regence reviews the following medications prior to Medicare coverage:
    • bevacizumab (Avastin) -- Effective 4/1/2010
    • Botulinum toxin
    • Immune globulin
    • Cetuximab (Erbitux) -- Effective 2/1/2010
    • Infliximab (Remicade)
    • Bortezomib (Velcade) -- Effective 2/1/2010
    • Omalizumab (Xolair)
    • Permetrexed (Alimta) -- Effective 4/1/2010
    • Rrituximab (Rituxan) -- Effective 4/1/2010